Microbial translocation and microbiome dysbiosis in HIV-associated immune activation
about
HIV-associated changes in the enteric microbial community: potential role in loss of homeostasis and development of systemic inflammationEffects of Fecal Microbial Transplantation on Microbiome and Immunity in Simian Immunodeficiency Virus-Infected MacaquesImmune activation and HIV: an enduring relationshipOne of the immune activation profiles observed in HIV-1-infected adults with suppressed viremia is linked to metabolic syndrome: The ACTIVIH study.Alterations in the Fecal Microbiota of Patients with HIV-1 Infection: An Observational Study in A Chinese Population.Soybean-derived Bowman-Birk Inhibitor (BBI) Inhibits HIV Replication in MacrophagesLoss of immune homeostasis dictates SHIV rebound after stem-cell transplantation.Toll-Like Receptor 2 Ligation Enhances HIV-1 Replication in Activated CCR6+ CD4+ T Cells by Increasing Virus Entry and Establishing a More Permissive Environment to Infection.Immune activation and neuroinflammation in alcohol use and HIV infection: evidence for shared mechanisms.Analysis and Interpretation of the Human Microbiome.Low abundance of colonic butyrate-producing bacteria in HIV infection is associated with microbial translocation and immune activation.The gut microbiome and HIV-1 pathogenesis: a two-way street.Strategies to limit immune-activation in HIV patients.Inflammatory colonic innate lymphoid cells are increased during untreated hiv-1 infection and associated with markers of gut dysbiosis and mucosal immune activation.Epigenetic Metabolite Acetate Inhibits Class I/II Histone Deacetylases, Promotes Histone Acetylation, and Increases HIV-1 Integration in CD4+ T Cells.Probiotic supplementation promotes a reduction in T-cell activation, an increase in Th17 frequencies, and a recovery of intestinal epithelium integrity and mitochondrial morphology in ART-treated HIV-1-positive patients.MicroRNA miR-126-5p Enhances the Inflammatory Responses of Monocytes to Lipopolysaccharide Stimulation by Suppressing Cylindromatosis in Chronic HIV-1 Infection.Highlights from the Conference on Retroviruses and Opportunistic Infections 2016: 22-25 February 2016, Boston, Massachusetts, USA.Mucosal Regulatory T Cells and T Helper 17 Cells in HIV-Associated Immune ActivationEfficacy and Safety of a Multistrain Probiotic Formulation Depends from Manufacturing.Impact of antiretroviral drugs on the microbiome: unknown answers to important questions.The microbiome and HIV persistence: implications for viral remission and cure.HIV-1 disease progression in immune-competent HIV-1-infected and breastfeeding mothers participating in the ANRS 12174 clinical trial in Burkina Faso, South Africa, Uganda and Zambia: a cohort study.Clearance of human papillomavirus related anal condylomas after oral and endorectal multistrain probiotic supplementation in an HIV positive male: A case report.Microbial Effects on Immunity in HIV: Virus, Gender or Sexual Preference Induced?Changes in intestinal microbiota in HIV-1-infected subjects following cART initiation: influence of CD4+ T cell count.Systemic DPP4 activity is reduced during primary HIV-1 infection and is associated with intestinal RORC+ CD4+ cell levels: a surrogate marker candidate of HIV-induced intestinal damage.
P2860
Q30839904-6FEDBE8F-6467-418C-A1D2-FEBB35D84125Q35943919-67588FAA-5620-4D26-8860-B084BCB7B21CQ36565474-689B7059-0D7F-4F18-A47E-E8B18D2F82BFQ37034835-DCCC19F0-96A6-4DCD-A095-A81026E773CCQ37141323-ABD508E6-3E16-4BDF-B80C-70A5F47BB0F4Q37335524-A0CD5D59-3C06-429B-917D-71AC70778B04Q37661792-00ACEBDC-DEC8-4261-9BC2-3C96B7510CD3Q38727201-234CE5D1-38EA-4ED0-840E-2EEB629A88BEQ38830540-E89C1903-0F8F-4955-921F-F8D7773D7D37Q38860462-6F5FF440-8963-4B80-87D6-AF6BF11F13CFQ38973447-97F496DC-9210-4905-8821-FA969E1996E2Q38984137-B5C1CECD-A269-4356-8527-4661F6EB165DQ38985926-1B0BF0BF-1C1B-4EC0-AFF8-865ABE4083D9Q40076719-AFE01559-6A81-4F40-A953-DF3AD9123CD5Q40187559-E9089C1D-4B65-4D4D-B901-84B897FA2EEAQ40225216-97E69DC5-CC51-4221-BCF4-6165C1CA3739Q40312229-B223EA15-5F07-4776-8CF8-41C9B876C7DCQ40591692-0BF83A6E-0C09-4EF5-86C0-12B362BC5409Q40625213-2B078D68-43D6-49C2-A057-50E4E15EFDC2Q44802067-E45EBD42-7944-4B44-8047-111C3E43B1A9Q46286824-5A0F7B6D-F2B9-402A-BB99-9F552CF40AE9Q47580980-6E21E2A8-A345-4D1E-B06C-AC69E4EA61EBQ53832060-5058C73C-D8E8-4E8A-9FCF-26B16F7A0D4EQ55261017-3134DC9C-4C8D-45B8-AE74-E934C3D8F9F4Q55311855-05C4C976-B999-45B0-A457-A8E88DDE13C2Q55442750-5AC3CF41-EE80-4C5A-813D-114BCA84B784Q55605404-3BB75F31-F3AE-4BF8-96E9-9BB65DA19076
P2860
Microbial translocation and microbiome dysbiosis in HIV-associated immune activation
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Microbial translocation and microbiome dysbiosis in HIV-associated immune activation
@ast
Microbial translocation and microbiome dysbiosis in HIV-associated immune activation
@en
type
label
Microbial translocation and microbiome dysbiosis in HIV-associated immune activation
@ast
Microbial translocation and microbiome dysbiosis in HIV-associated immune activation
@en
prefLabel
Microbial translocation and microbiome dysbiosis in HIV-associated immune activation
@ast
Microbial translocation and microbiome dysbiosis in HIV-associated immune activation
@en
P2093
P2860
P1476
Microbial translocation and microbiome dysbiosis in HIV-associated immune activation
@en
P2093
Adam Burgener
Alexander S Zevin
Nichole R Klatt
P2860
P304
P356
10.1097/COH.0000000000000234
P577
2015-12-16T00:00:00Z